Owens & Minor (NYSE:OMI) Given New $20.00 Price Target at Robert W. Baird

Owens & Minor (NYSE:OMI) had its price target cut by Robert W. Baird from $24.00 to $20.00 in a research report released on Tuesday, Benzinga reports. They currently have a neutral rating on the stock.

OMI has been the subject of a number of other reports. Leerink Partnrs reiterated a market perform rating on shares of Owens & Minor in a research note on Monday, February 26th. Citigroup boosted their target price on shares of Owens & Minor from $24.00 to $28.00 and gave the company a neutral rating in a research note on Tuesday, April 30th. SVB Leerink began coverage on shares of Owens & Minor in a research note on Monday, February 26th. They set a market perform rating and a $24.00 target price for the company. StockNews.com lowered shares of Owens & Minor from a buy rating to a hold rating in a research note on Thursday, May 23rd. Finally, TheStreet raised shares of Owens & Minor from a d+ rating to a c- rating in a research report on Monday, March 4th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, Owens & Minor presently has a consensus rating of Hold and an average target price of $21.88.

Owens & Minor Price Performance

Shares of NYSE OMI opened at $13.50 on Tuesday. Owens & Minor has a twelve month low of $13.26 and a twelve month high of $28.35. The firm has a market cap of $1.03 billion, a P/E ratio of -26.47, a PEG ratio of 0.47 and a beta of 0.33. The company has a 50 day moving average of $18.71 and a 200 day moving average of $21.23. The company has a quick ratio of 0.56, a current ratio of 1.16 and a debt-to-equity ratio of 2.17.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Friday, May 3rd. The company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The company had revenue of $2.61 billion during the quarter, compared to analyst estimates of $2.61 billion. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.05 EPS. As a group, research analysts expect that Owens & Minor will post 1.53 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Mark A. Beck sold 9,344 shares of the company’s stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $17.25, for a total value of $161,184.00. Following the completion of the transaction, the director now owns 11,154 shares of the company’s stock, valued at approximately $192,406.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Mark A. Beck sold 9,344 shares of the company’s stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $17.25, for a total value of $161,184.00. Following the completion of the transaction, the director now owns 11,154 shares of the company’s stock, valued at approximately $192,406.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Alexander J. Bruni sold 10,568 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $17.76, for a total transaction of $187,687.68. Following the completion of the transaction, the chief financial officer now directly owns 49,950 shares of the company’s stock, valued at approximately $887,112. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,923 shares of company stock valued at $686,911. Company insiders own 3.59% of the company’s stock.

Institutional Trading of Owens & Minor

Several hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC lifted its stake in Owens & Minor by 52.1% in the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock worth $46,000 after purchasing an additional 563 shares in the last quarter. Rhumbline Advisers lifted its stake in Owens & Minor by 0.3% in the 3rd quarter. Rhumbline Advisers now owns 247,846 shares of the company’s stock worth $4,005,000 after purchasing an additional 660 shares in the last quarter. Quarry LP lifted its stake in Owens & Minor by 38.8% in the 4th quarter. Quarry LP now owns 2,573 shares of the company’s stock worth $50,000 after purchasing an additional 719 shares in the last quarter. Riverview Trust Co purchased a new stake in Owens & Minor in the 1st quarter worth $25,000. Finally, ProShare Advisors LLC lifted its stake in Owens & Minor by 7.4% in the 1st quarter. ProShare Advisors LLC now owns 15,021 shares of the company’s stock worth $416,000 after purchasing an additional 1,029 shares in the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.